-
Study aim
-
Evaluation of the effect of scalp block on pain control and the amount of drug use during and after surgery in patients with elective craniotomy
-
Design
-
This randomized clinical trial will be conducted in 1401 at Sinai Hospital. In this study, adult patients aged 18 to 65 years with ASA status I and II who are to undergo elective craniotomy will be evaluated. They will be randomly divided into two groups of 36 so that the first group will receive the scalp block (intervention) and the second group will not receive the scalp block as a control.
-
Settings and conduct
-
This study will be performed as a randomized clinical trial in patients undergoing craniotomy at Sina Hospital. Two ANI monitor probes will be in the right place. In the scalp block group, unilateral scalp block will be performed under sterile conditions with bupivacaine
-
Participants/Inclusion and exclusion criteria
-
Study population: patients candidates for craniotomy
Inclusion criteria: 1) Patients between 18 and 70 years old, 2) Candidate patients for craniotomy surgery, 3) ASA grade I-II and 4) Consent to enter the study
Exclusion criteria: 1) Patients with arrhythmia, 2) Patients taking beta-blockers, 3) Pregnant women, 4) Patients for whom preoperative or postoperative ANI monitoring was discontinued. 5) Patients who had pre-operative beta-blocker injections, 6) Dissatisfaction with inclusion in the study, and 7) Patient non-cooperation
-
Intervention groups
-
Patients will be randomly divided into two groups so that the first group will receive scalp block (intervention) and the second group will not receive scalp block as a control.
-
Main outcome variables
-
Hemodynamic parameters during induction, Intubation, fixation of headpins, skin incision, craniotomy, and while waking the patient as well as the amount of remifentanil received during these times will be recorded and compared between the two groups.